Novel ethical and policy issues in psychiatric uses of psychedelic substances
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel ethical and policy issues in psychiatric uses of psychedelic substances
Authors
Keywords
-
Journal
NEUROPHARMACOLOGY
Volume 216, Issue -, Pages 109165
Publisher
Elsevier BV
Online
2022-06-17
DOI
10.1016/j.neuropharm.2022.109165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Rapid Rise in Investment in Psychedelics—Cart Before the Horse
- (2022) Joshua Phelps et al. JAMA Psychiatry
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
- (2021) Jennifer M. Mitchell et al. NATURE MEDICINE
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two Models of Legalization of Psychedelic Substances
- (2021) William R. Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness
- (2021) Morgan Campbell et al. Frontiers in Psychiatry
- Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems
- (2021) Elena Argento et al. Frontiers in Psychiatry
- Legalization of Psychedelic Substances
- (2021) Luke A. Downey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Legalization of Psychedelic Substances
- (2021) Michael D. Alpert JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Legalization of Psychedelic Substances—Reply
- (2021) William R. Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Legalization of Psychedelic Substances
- (2021) Mason Marks JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Psychedelic therapy: a roadmap for wider acceptance and utilization
- (2021) Mason Marks et al. NATURE MEDICINE
- Psychedelics and Psychedelic-Assisted Psychotherapy
- (2020) Collin M. Reiff et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ethics and ego dissolution: the case of psilocybin
- (2020) William R Smith et al. JOURNAL OF MEDICAL ETHICS
- Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways
- (2020) Holly Fernandez Lynch et al. JOURNAL OF LAW MEDICINE & ETHICS
- Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails
- (2020) David B. Yaden et al. JAMA Psychiatry
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Accelerated Approval of Cancer Drugs—Righting the Ship of the US Food and Drug Administration
- (2019) Sarah S. P. DiMagno et al. JAMA Internal Medicine
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
- (2018) Matthew W. Johnson et al. NEUROPHARMACOLOGY
- Psychedelics: Where we are now, why we got here, what we must do
- (2018) Sean J. Belouin et al. NEUROPHARMACOLOGY
- Effects of Schedule I drug laws on neuroscience research and treatment innovation
- (2013) David J. Nutt et al. NATURE REVIEWS NEUROSCIENCE
- Balancing Access and Evaluation in the Approval of New Cancer Drugs
- (2011) Franklin G. Miller JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Empirical evaluation of the need for ‘on-going consent’ in clinical research
- (2010) William Smith et al. AIDS
- Drug harms in the UK: a multicriteria decision analysis
- (2010) David J Nutt et al. LANCET
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started